|
醫學研究科
[醫研科行政業務]
[動物研究實驗室]
[心臟血管研究室] [神經結構與功能研究室] [流行病學研究室]
[細胞藥理學研究室] [基因工程研究室]
[感染疾病與免疫學研究室] [癌症基因體研究室]
Welcome!
Laboratory of Genetic Engineering is located at 4th Floor of the
Building of Medical Research in the Veterans
General Hospital- Kaohsiung.
Principal Investigator: Ph.
D. Ming-Hong Tai(本院特聘研究員)
TEL: (07) 342-2121 ext.
1511 FAX: (07)346-8056
Address: 高雄市左營區大中一路386號 高雄榮總
教學研究部
Department of Medical Education and Research
Veterans General Hospital-Kaohsiung
386 Ta-Chung 1st Road Kaohsiung,
Taiwan 813
E-mail: prlin@vghks.gov.tw
主持人(Principal
investigator) 其他成員
(Members)
Associated
Investigator
Ph.D. Tai, Ming-Hong
戴明泓 博士(本院特聘研究員) TEL: (07)342-2121
ext. 1510 E-mail:mhtai@isca.vghks.gov.tw
1.?鑑別新的分子標幟以應用於肝炎的診斷及治療
肝癌在台灣高居死亡率之冠,
然而肝癌的致病機轉目前仍不清楚。過去三年來,
我們分析腫瘤抑制基因PTEN在肝癌組織的表現發現:
將近40%的肝癌病人其肝癌組織有PTEN基因表現缺失的情況。基於此,
我們運用腺病毒載體回復肝癌細胞PTEN基因的表現後,發現此方式可有效的降低肝癌細胞在裸鼠身上生長的情形。
目前, 我們嘗試發展原發性肝癌的動物模式,以用於評估以PTEN
基因對肝癌動物模式進行治療之效能及可行性。
2. 血管新生的分子機制
血管新生--即生成新血管的過程--在正常的生理狀態
下及許多人類疾病 (如:癌症、類風濕性關節炎)上扮演
極重要的角色。此現象的發生,端賴眾多促進或抑制血管新生的因子的參與。我們研究室已成功的生產並純畫出血管新生抑制因子(endostatin及vasostatin),及血管心生促進因子(bFGF,aFGF,VEGF及HDGF)。藉著活體外(in
vitro)及活體內(in vivo)的相關研究,我們希望可以開發這些因子在臨床上的應用方向,同時對血管新生的機制有更清楚的了解。
3. 以神經生長因子促進神經再生
因為神經細胞無法再生的特性,使得
神經創傷後或神經退化後再促進神經再生的工作顯得更加艱巨。於目前的研究中,我們已證實以神經生長因子基因治療脊髓傷害後的大鼠,其神經受損情形有減緩的現象,但同時也加劇其神經痛的情況。未來,我們將繼續探索合併基因治療的方法,以提升神經再生因子基因治療之發展潛能。
Research interests
Genetic engineering has become the premium technology to
enhance the national economies and to improve the welfare of human
beings. The ultimate goal of our laboratory is to develop
gene-based strategies for diagnosis and treatment of intractable
diseases. At present, our groups are focusing on the following
biological questions:
1. Identification of Novel Molecular Markers for Diagnosis and
Treatment of Hepatocellular Carcinoma (HCC).
HCC is the leading cause for mortality in Taiwan. However, the
mechanism underlying liver carcinogenesis remains unclear. In the
last three years, we analyzed the expression of tumor suppressor
gene PTEN in HCC specimens and found that loss of PTEN expression
occurs in nearly 40% of HCC patients. Subsequently, we utilized
adenovirus vector to restore PTEN expression and found that PTEN
gene delivery effectively reduced the growth of hepatoma in nude
mice. At present, we are developing orthotopic hepatoma model to
evaluate the efficacy of PTEN gene delivery for treatment of
hepatoma in immune competent animals.
2. Molecular Mechanism of Angiogenesis
Angiogenesis, the process of growing new blood vessels, plays
an important role in physiological process and pathogenesis of
human diseases such as cancer, rheumatoid arthritis. Many positive
and negative factors participate in the process of angiogenesis.
In our laboratory, we have generated recombinant angiogenesis
inhibitors such as endostatin, vasostatin, and angiogenic factors
such as bFGF, aFGF, VEGF, and HDGF. By studying the functions of
these factors in vitro and in vivo, we hope to explore the
clinical application of these factors, but also shed lights on the
mechanism of angiogenesis.
3. Neuroregeneration by gene delivery of neurotrophic factors
To promote regeneration of central nerve system (CNS) after
trauma or degeneration is considered a huge task because of the
inability of CNS to regrow. In our recent studies, we demonstrated
the feasibility of using gene delivery of trophic factor, GDNF to
promote the recovery of rats after spinal cord injury, to
alleviate the neuropathic pain in rats with nerve injury. In the
future, we will also explore the potential and efficacy of
combinatory gene therapy to enhance neuroregeneration.
Education
1980-1984 B. S., Chemistry National Cheng-Kung University
1984-1986 M. S., Biochemistry National Taiwan University
1988-1993 Ph. D., Biochemistry Baylor College of Medicine
1993-1994 Postdoctoral fellow Baylor College of Medicine
1994-1996 Postdoctoral fellow The Scripps Research Institute
A.
期刊論文
1.
Sheu, S.-J., Chou, L.-C., Bi, Y.-S., Chen, J.-F., Lin, H.-C.,
Lin, P.-R., Lam, H.-C. and Tai, M.-H.* Suppression of
Choroidal Neovascularization by Intramuscular Polymer-based Gene
Delivery of Vasostatin Exp. Eye Res. In press (SCI; *:
corresponding author) (IF: 2.611; 7/41=17.07%)
2.
Wu, P.-C., Yang, L.-C., Kuo, H.-K., Huang, C.-C., Tsai, C.-L.,
Lin, P.-R., Wu, P.-C., Shin, S.-J., Tai, M.-H.*
Inhibition of corneal angiogenesis by local application of
vasostatin Molecular Vision 11:28-35, 2005 (SCI; *:
corresponding author) (IF: 2.777; 6/41=14.63%)
3.
Tai, M.-H, Wang L.-L., Kay L.H. Wu, Julie Y.H.
Chan Increased superoxide anion in rostral ventrolateral medulla
contributes to hypertension in spontaneously hypertensive rats via
interactions with nitric oxide Free Radical Biology &
Medicine 38(4):450-62, 2005 (SCI) (IF: 5.063; 43/261 =
16.47%)
4.
Chou, A. K., Yang, L. C., Lin, T. R., Lin, P. R., Tai,
M. H.* Amelioration of paraplegia with spinal ischemia by
gene delivery of glial cell line-derived neurotrophic factor Brain.
Res. Mol. Brain. Res. 133
(2):198-207, 2005 (SCI; *: corresponding author) (IF: 2.107; 100/198
= 50.50%)
5.
Huang CC, Chuang, J.-H., Chou, M.-H., Wu, C.-L., Chen, C.-M.,
Wang, C.-C., Chen, Y.-S., Chen, C.-L. and Tai,
M-H. Matrilysin (MMP-7) is a major
matrix metalloproteinase up-regulated in biliary atresia-associated
liver fibrosis. Modern Pathology
in press 2005 (SCI)
6.
Hu, T.-H., Huang, C.-C., Wu, C.-L., Lin, P.-R., Liu, S.-Y.,
Lin, J.-W., Chuang, J.-H., Tai, M.-H* Increased
Endostatin/Collagen XVIII Expression Correlates with Elevated VEGF
Level and Poor Prognosis in Hepatocellular Carcinoma. Modern
Pathology 18(5): 663-72, 2005 (SCI; *: corresponding author)
(IF: 3.643; 10/64 = 15.62%)
7.
Hsiao CC, Huang CC, Sheen JM, Tai, M-H, Chen CM,
Huang LL, Chuang JH. Differential expression of delta Differential
expression of delta-like gene and protein in neuroblastoma,
ganglioneuroblastoma and ganglioneuroma. Modern
Pathology 18: 656-662, 2005 (SCI)
8.
Chuang, J.-H., Wang, Pei-Wen and Tai, M-H. An
adipocentric view of liver fibrosis and cirrhosis The Chung
Gung Medical Journal 27 (12): 855-868, 2004.
9.
Cho, F. N., Kan, Y. Y., Yang, T. L., Huang, H. P., Hsu, P. H.,
Tai, M. H. Prenatal diagnosis of sharp-angled
lumbosacral kyphosis with myelomeningocele and spina bifida in a
fetus. Journal of Ultrasound Medicine 23(8):1115-9,
2004. (SCI)
10.
Tai, M. H.,
Hsiao M, Chan JY, Lo WC, Wang FS, Liu GS, Howng SL, Tseng CJ. Gene
delivery of endothelial nitric oxide synthase into nucleus tractus
solitarii induces biphasic response in cardiovascular functions of
hypertensive rats American Journal of Hypertension
17(1): 63-70, 2004 (SCI) (IF: 3.382; 13/51 = 25.49%)
11.
Hu, T. H., Huang, C. C., Ma, Y. L., Liu L. F., Liang, H. T., Kao, Y.
H., Lin, P. R., Goto, S., Chen, C. L., Lee, C. H., and Tai, M.
H.* The Expression of Hepatoma-derived Growth Factor in
Hepatocellular Carcinoma: A novel prognostic factor Cancer
98(7):1444-56, 2003 (SCI; *: corresponding author) (IF: 4.434;
22/120 = 17.89%)
12.
Tai, M. H.,
Cheng, H., Wu, J.P., Liu, Y.L., Lin, P.R., Kuo, J.S., C.J.Tseng, and
S.F. Tzeng Gene transfer of glial cell line-derived neurotrophic
factor promotes functional recovery following spinal cord contusion Experimental
Neurology 183(2):508-15, 2003 (SCI) (IF: 3.676; 42/198 =
21.21%)
13.
Hu, T. H., Huang, C. C., Lin, P. R., Chang, H. W., Ger, L. P., Lin,
Y. W., Changchien, C. S., Lee, C. M., and Tai, M. H.*.
Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1
in hepatocellular carcinoma. Cancer 97, 1929-40, 2003.
(SCI; *: corresponding author) (IF: 4.434; 22/123 = 17.89%)
14.
Chau, Y. P., Liu, T. J., Lin, S. Y., Chen, J. H. C., Tai, M. H.*.
Endostatin induced autophagic cell death in human endothelial cells Histology
and Histopathology 18 (3): 715-26, 2003
(SCI; *: corresponding author) (IF: 1.83; 25/64 = 39.06%)
15.
Lee, Y. C., Chien, C. L., Sun, C. N., Huang, C. L., Huang, N. K.,
Chiang, M. C., Lai, H. L., Lin, Y. S., Chou, S. Y., Wang, C. K., Tai,
M. H., Liao, W. L., Lin, T. N., Liu, F. C., Chern, Y.
Characterization of the rat A2A adenosine receptor gene: a 4.8-kb
promoter-proximal DNA fragment confers selective expression in the
central nervous system Eur. J. Neurosci.
18(7):1786-96, 2003. (SCI) (IF: 3.876; 37/198 = 18.68%)
16.
Lin, C. R., Yang, L. C., You, H. L., Lee, C. T., Tai, M. H.,
Tan, P. H., Lin, M. W., and Cheng, J. T. Antinociceptive
Potentiation and Attenuation of Tolerance by Intrathecal Electric
Stimulation in Rats. Anesth. Analg. 96, 1711-1716
2003. (SCI)
17.
Wang, Y. F., Lee, S. B., Cheng LC, Tai, M. H., Su, I.
J. Detection of serum antibodies to three different recombinant
antigens of human herpesvirus 8 by immunoblotting: seroprevalence
studies in Taiwan. Clin. Chim. Acta. 320(1-2):37-42,
2002 (SCI)
18.
Lin, C. R., Tai, M. H., Cheng, J. T., Chou, A. K.,
Wang, J. J., Tan, P. H., Marsala, M., Yang, L. C. Electroporation
for direct spinal gene transfer in rats Neuroscience
Letters 317:1-4, 2002 (SCI) (IF: 1.967; 107/198 = 54.04%)
19.
Krushel L. A., Tai, M. H., Cunningham, B. A., Edelman,
G. M. Crossin, K. L. N-CAM domains and intracellular signaling
pathways involved in the inhibition of astrocyte proliferation. Proc.
Natl. Acad. Sci. USA. 95(5):2592-2596, 1998. (SCI)
20.
Crossin, K. L., Tai, M. H., Krushel L. A., Mauro, V.
P., Edelman, G. M. Glucocorticoids receptor pathways are
involved in the inhibition of astrocyte proliferation. Proc.
Natl. Acad. Sci. USA. 94:2687-2692, 1997. (SCI)
21.
Jayakumar, A.*, Tai, M. H.*, Huang, W. Y., Al-Feel,
W., Hsu, M., Abu-Elheiga, L., Chirala, S. S., Wakil, S. J. Human
fatty acid synthase: properties and molecular cloning. Proc.
Natl. Acad. Sci. USA. 92(19): 8695-9, 1995. (*: equal
contribution) (SCI)
22.
Tai, M. H.,
Chirala, S. S., Wakil, S. J. Roles of Ser101, Asp236, and His237 in
catalysis of thioesterase II and of the C-terminal region of the
enzyme in its interaction with fatty acid synthase. Proc.
Natl. Acad. Sci. USA. 90 (5):1852-6, 1993. (SCI)
B.
研討會論文
1.
Tai, M. H.,
Crossin, K. L., Edelman, G. M. Cytotactin upregulates gene
expression of translationally controlled tumor protein in chicken
embryo brain cells. Society for Neuroscience Vol.
23:92, 45.7, 1997.
2.
Crossin, K. L., Tai, M. H., Krushel, L. A., Mauro, V.
P., Edelman, G. M. Glucocorticoid receptor pathways are
involved in inhibition of astrocyte proliferation. Society
for Neuroscience Vol. 23:70, 37.1, 1997.
3.
Krushel, L. A., Tai, M. H., Ranheim. T. S.,
Cunningham, B. A., Edelman, G. M., Crossin, K. L. Signal
pathways associated with inhibition of glial proliferation by N-CAM.
Society for Neuroscience Vol. 23:70, 37.2, 1997.
4.
Lin, P. R., Tai, M. H. Cloning, expression and
purification of the cytoplasmic domain of neuronal adhesion molecule
DCC. Abstracts in Annual Meeting of Society for Basic Neuroscience, 1997
中華民國基礎神經科學學會
5.
Tai, M. H., Chiang, C. Y., Lin, P. R., Tseng, C. J.
Mapping the transactivation domains within the cytoplasmic domain of
Deleted in Colorectal Cancer (DCC). 28th
Annual Meeting of Society for Neuroscience Vol. 24:1069, 424.17,
1998.
6.
J. H. C., Wu, S. N., Tai, M. H. Electrophysiological
studies on the effects of endostatin in endothelial cells Special
conference “New Targets for Cancer Intervention” by American
Association for Cancer Research, 2000.
7.
Ming-Hong Tai, Pey-Ru Lin, Tsong-Hwei Hu PTEN Gene delivery
for suppression of hepatoma. Molecular Therapy Vol. 3 No. 5:
S341-963, May 2001. 4th
Annual Meeting for American Society of Gene Therapy,
Seattle, USA
8.
James Heng-Chi Chen, Sheng-Nan Wu, and Ming-Hong Tai Endostatin
Induced Calcium Rise and Stimulated Large-conductance,
Calcium-activated Potassium Channel in Endothelial Cells Vol. 1 No.
913 16th Protein Society Meeting, 2002, San Diego,
USA
9.
Pey-Ru Lin, Ming-Hong Tai PTEN gene delivery
suppressed PTEN-defective hepatoma Abstract Book No. 238, 11th
Annual Congress of European Society of Gene Therapy, 2003.
Edinburg, UK.
10.
Ming-Hong Tai, An-Kuo Chou, Yu-Ming Kuo Gene Delivery
of Glial Cell line-Derived Neurotrophic Factor Ameliorated
Paraplegia in Rats
after Spinal Ischemia. 34th Annual
Meeting of The Society for Neuroscience, 2004 San Diego, USA
11.
Guei-Sheung Liu, Chiou-Lian Lai, Sheng-Long Howng and Ming-Hong
Tai Peripheral Gene Delivery of Glial Cell Line-derived
Neurotrophic Factor Alleviated Neurological Deficits in Diabetic
Rats Molecular Therapy Vol. 11 (1): S549, June 2005. 8th Annual Meeting for American
Society of Gene Therapy, St.
Louis, USA
C.
專書及專書論文
1.
Tai, M. H.
“Expression, Purification, and Mutagenesis Studies of Rat Mammary
Gland Medium-chain S-acyl Fatty Acid Synthase Thioesterase II (TE
II) Ph.D. Thesis, 1993. Dept. of Biochemistry, Baylor College of
Medicine, USA.
2.
Tai, M. H.
Chapter 14 Expression of tumor suppressor gene PTEN in
hepatocellular carcinoma Handbook for Immunohistochemistry and In
Situ Hybridization Vol. 2 (published by Elsevier Science/Academic
Press; 2005 in press)
D.
技術報告及其他
1.
Tai, M. H.「評估腫瘤生長與轉移之冷光癌症模式」(國科會計劃編號NSC
93-2622-B-075B-001-CC3; 技術移轉至冷泉港生物科技公司)
2.
Tai, M. H.
Liu, S. Y. “ST104P, An Anti-angiogenic Agent” (Application for
US patent)
Members
|
Assistant
investigators
|
|
| 孔美蘭 |
高雄醫學大學
生物化學研究所 |
| 尤碩瑜 |
|
|
Students
|
|
| 博士班
劉貴玄 |
高雄醫學大學 醫學研究所 |
|
郭孝美
|
國立中山大學
生物科學研究所 |
|
畢勇賢
|
國立中山大學
生物科學研究所 |
|
馬怡玲
|
國立中山大學
生物科學研究所 |
| 碩士班
吳靖怡 |
國立中山大學 生物科學研究所 |
|
蔡函恩
|
國立中山大學
生物醫學研究所 |
|
錢信帆
|
國立中山大學
生物醫學研究所 |
|
張梓庭
|
國立中山大學
生物科學研究所 |
|
徐明祿 |
國立中山大學
生物科學研究所 |
|
耿秀曼
|
國立中山大學
生物科學研究所 |
|
林怡君
|
國立中山大學
生物科學研究所 |
|